155 related articles for article (PubMed ID: 23563593)
21. Effects of lobeglitazone, a novel thiazolidinedione, on adipose tissue remodeling and brown and beige adipose tissue development in db/db mice.
Kim G; Lee YH; Yun MR; Lee JY; Shin EG; Lee BW; Kang ES; Cha BS
Int J Obes (Lond); 2018 Mar; 42(3):542-551. PubMed ID: 28895584
[TBL] [Abstract][Full Text] [Related]
22. PPARγ Antagonist Gleevec Improves Insulin Sensitivity and Promotes the Browning of White Adipose Tissue.
Choi SS; Kim ES; Jung JE; Marciano DP; Jo A; Koo JY; Choi SY; Yang YR; Jang HJ; Kim EK; Park J; Kwon HM; Lee IH; Park SB; Myung KJ; Suh PG; Griffin PR; Choi JH
Diabetes; 2016 Apr; 65(4):829-39. PubMed ID: 26740599
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological profile of a novel, non-TZD PPARgamma agonist.
Chen X; Osborne MC; Rybczynski PJ; Zeck R; Yang M; Xu J; Zhou L; Cryan E; Tang Y; Demarest KT
Diabetes Obes Metab; 2005 Sep; 7(5):536-46. PubMed ID: 16050946
[TBL] [Abstract][Full Text] [Related]
24. Platycodin D, a novel activator of AMP-activated protein kinase, attenuates obesity in db/db mice via regulation of adipogenesis and thermogenesis.
Kim HL; Park J; Jung Y; Ahn KS; Um JY
Phytomedicine; 2019 Jan; 52():254-263. PubMed ID: 30599906
[TBL] [Abstract][Full Text] [Related]
25. Cilostazol ameliorates metabolic abnormalities with suppression of proinflammatory markers in a db/db mouse model of type 2 diabetes via activation of peroxisome proliferator-activated receptor gamma transcription.
Park SY; Shin HK; Lee JH; Kim CD; Lee WS; Rhim BY; Hong KW
J Pharmacol Exp Ther; 2009 May; 329(2):571-9. PubMed ID: 19221061
[TBL] [Abstract][Full Text] [Related]
26. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice.
Memon RA; Tecott LH; Nonogaki K; Beigneux A; Moser AH; Grunfeld C; Feingold KR
Endocrinology; 2000 Nov; 141(11):4021-31. PubMed ID: 11089532
[TBL] [Abstract][Full Text] [Related]
27. GQ-16, a TZD-Derived Partial PPARγ Agonist, Induces the Expression of Thermogenesis-Related Genes in Brown Fat and Visceral White Fat and Decreases Visceral Adiposity in Obese and Hyperglycemic Mice.
Coelho MS; de Lima CL; Royer C; Silva JB; Oliveira FC; Christ CG; Pereira SA; Bao SN; Lima MC; Pitta MG; Pitta IR; Neves FA; Amato AA
PLoS One; 2016; 11(5):e0154310. PubMed ID: 27138164
[TBL] [Abstract][Full Text] [Related]
28. Thiazolidinediones and rexinoids induce peroxisome proliferator-activated receptor-coactivator (PGC)-1alpha gene transcription: an autoregulatory loop controls PGC-1alpha expression in adipocytes via peroxisome proliferator-activated receptor-gamma coactivation.
Hondares E; Mora O; Yubero P; Rodriguez de la Concepción M; Iglesias R; Giralt M; Villarroya F
Endocrinology; 2006 Jun; 147(6):2829-38. PubMed ID: 16513826
[TBL] [Abstract][Full Text] [Related]
29. The effects of obesity-associated insulin resistance on mRNA expression of peroxisome proliferator-activated receptor-gamma target genes, in dogs.
Gayet C; Leray V; Saito M; Siliart B; Nguyen P
Br J Nutr; 2007 Sep; 98(3):497-503. PubMed ID: 17475082
[TBL] [Abstract][Full Text] [Related]
30. Selective PPARγ modulator diosmin improves insulin sensitivity and promotes browning of white fat.
Yu J; Hu Y; Sheng M; Gao M; Guo W; Zhang Z; Wang D; Wu X; Li J; Chen Y; Zhao W; Liu C; Cui X; Chen X; Zhao C; Chen H; Xiao J; Chen S; Luo C; Xu L; Gu X; Ma X
J Biol Chem; 2023 Apr; 299(4):103059. PubMed ID: 36841479
[TBL] [Abstract][Full Text] [Related]
31. Multi-tissue, selective PPARγ modulation of insulin sensitivity and metabolic pathways in obese rats.
Hsiao G; Chapman J; Ofrecio JM; Wilkes J; Resnik JL; Thapar D; Subramaniam S; Sears DD
Am J Physiol Endocrinol Metab; 2011 Jan; 300(1):E164-74. PubMed ID: 20959535
[TBL] [Abstract][Full Text] [Related]
32. Hot water extracts of edible Chrysanthemum morifolium Ramat. exert antidiabetic effects in obese diabetic KK-Ay mice.
Yamamoto J; Tadaishi M; Yamane T; Oishi Y; Shimizu M; Kobayashi-Hattori K
Biosci Biotechnol Biochem; 2015; 79(7):1147-54. PubMed ID: 25665595
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, and biological evaluation of a series of alkoxy-3-indolylacetic acids as peroxisome proliferator-activated receptor γ/δ agonists.
Gim HJ; Li H; Jeong JH; Lee SJ; Sung MK; Song MY; Park BH; Oh SJ; Ryu JH; Jeon R
Bioorg Med Chem; 2015 Jul; 23(13):3322-36. PubMed ID: 25982078
[TBL] [Abstract][Full Text] [Related]
34. Loss of PPAR gamma in immune cells impairs the ability of abscisic acid to improve insulin sensitivity by suppressing monocyte chemoattractant protein-1 expression and macrophage infiltration into white adipose tissue.
Guri AJ; Hontecillas R; Ferrer G; Casagran O; Wankhade U; Noble AM; Eizirik DL; Ortis F; Cnop M; Liu D; Si H; Bassaganya-Riera J
J Nutr Biochem; 2008 Apr; 19(4):216-28. PubMed ID: 17618105
[TBL] [Abstract][Full Text] [Related]
35. PPARgamma differentially regulates energy substrate handling in brown vs. white adipose: focus on "The PPARgamma agonist rosiglitazone enhances rat brown adipose tissue lipogenesis from glucose without altering glucose uptake".
Grobe JL; Venegas-Pont M; Sigmund CD; Ryan MJ
Am J Physiol Regul Integr Comp Physiol; 2009 May; 296(5):R1325-6. PubMed ID: 19261916
[No Abstract] [Full Text] [Related]
36. Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor gamma activation has coordinate effects on gene expression in multiple insulin-sensitive tissues.
Way JM; Harrington WW; Brown KK; Gottschalk WK; Sundseth SS; Mansfield TA; Ramachandran RK; Willson TM; Kliewer SA
Endocrinology; 2001 Mar; 142(3):1269-77. PubMed ID: 11181544
[TBL] [Abstract][Full Text] [Related]
37. Effects of DSP-8658, a novel selective peroxisome proliferator-activated receptors a/γ modulator, on adipogenesis and glucose metabolism in diabetic obese mice.
Goto T; Nakayama R; Yamanaka M; Takata M; Takazawa T; Watanabe K; Maruta K; Nagata R; Nagamine J; Tsuchida A; Kato H
Exp Clin Endocrinol Diabetes; 2015 Sep; 123(8):492-9. PubMed ID: 26011171
[TBL] [Abstract][Full Text] [Related]
38. Effects of combined PPAR-γ and PPAR-α agonist therapy on fructose induced NASH in rats: Modulation of gene expression.
Abd El-Haleim EA; Bahgat AK; Saleh S
Eur J Pharmacol; 2016 Feb; 773():59-70. PubMed ID: 26825546
[TBL] [Abstract][Full Text] [Related]
39. 18F9 (4-(3,6-bis (ethoxycarbonyl)-4,5,6,7-tetrahydrothieno (2,3-c) pyridin-2-ylamino)-4-oxobutanoic acid) enhances insulin-mediated glucose uptake in vitro and exhibits antidiabetic activity in vivo in db/db mice.
Anandharajan R; Sayyed SG; Doshi LS; Dixit P; Chandak PG; Dixit AV; Brahma MK; Deshmukh NJ; Gupte R; Damre A; Suthar J; Padigaru M; Sharma SD; Nemmani KV
Metabolism; 2009 Oct; 58(10):1503-16. PubMed ID: 19608207
[TBL] [Abstract][Full Text] [Related]
40. PPARgamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo.
Kershaw EE; Schupp M; Guan HP; Gardner NP; Lazar MA; Flier JS
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1736-45. PubMed ID: 17848638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
